Stock listing

SGX:42C iX Biopharma Ltd. Share Price

Follow iX Biopharma Ltd. into a list and get an email when it puts out news.

iX Biopharma Ltd. logo
Ticker
SGX:42C
Asset type
Stock
Exchange
SGX
Currency
SGD

What changed lately

Latest news

General Announcement: : Press Release: iX Biopharma Commences Supply of Medicinal Cannabis Wafers to Brazil

Jun 28, 2021

IX Biopharma is pleased to announce that it will supply its novel Wafermine sublingual ketamine wafers in a pilot study funded by Chris O’Brien Lifehouse, one of Australia’s leading comprehensive cancer hospitals in Camperdown, Sydney. The study will evaluate the efficacy, acceptability, safety and tolerability of Wafermine administered as a first-line treatment for patients with advanced cancer suffering from moderate to severe pain.

Jun 15, 2021

IX Biopharma Expands Wafer Production Capacity to Meet Growing Demand

Jun 2, 2021

IX Biopharma is pleased to announce that the United States Food and Drug Administration (US FDA) has granted the Company an orphan drug designation for treatment of patients with Complex Regional Pain Syndrome (CRPS) with ketamine.

May 18, 2021

IX Biopharma is pleased to announce that it has received positive feedback from the European Medicines Agency (EMA) in its scientific advice to the Company regarding its Phase 3 clinical development programme for Wafermine, its sublingual ketamine wafer, for registration in Europe.

Nov 10, 2020

IX Biopharma obtains approval and registration of Silcap for the treatment of male erectile dysfunction in Singapore

Oct 21, 2020

All iX Biopharma Ltd. news

Decks

iX Biopharma Ltd. on 6ix

News releases
7 in all · newest Jun 28, 2021 · oldest 2020
Decks
4 decks · latest Sep 23, 2026

Log in to ask 6ix AI your own questions about iX Biopharma Ltd.